Sr Clinical Project Manager

Role Description

Our Sr Clinical Project Manager is responsible for management of multiple projects (including global projects) throughout all lifecycle phases. Ensures that all project work is completed to the client expectations, ensuring quality deliverables on time and within budget and in accordance with SOPs, ICH GCP, applicable regulations, policies and practices. Serves as the principal liaison with clients to ensure effective and timely communication of project progress, issues, and plans for resolution of those issues.

• Provides leadership in the development of clinical trials and related documents.
• Works closely and effectively with cross-functional teams.
• Mentors and assists in the development of project team members.
• Participates in PM department initiatives, process improvement, and training programs.
• Provides strategy and input in business development proposals and attends bid defenses.

This is a remote position based in the US; relocation assistance and visa sponsorship are not available.

Qualifications

• Bachelor Degree required, Master's Degree preferred.
• 5-7+ years' professional experience in clinical research, pharmaceutical, or life sciences industries as a Project Manager, leading and directing other team members.
• Full understanding of drug development process with experience with the critical elements for success in clinical trials; participation in and contribution to all activities.
• Experience reviewing protocols, programs, and assessing the success of a project.
• Experience with budgeting, forecasting, and resource utilization for the clinical trial.

Benefits

• Comprehensive benefits to support physical, mental, and financial well-being.
• Competitive compensation package determined by performance, experience, skills, equity, regular job market evaluations, and geographical markets.
• Other compensation, such as an annual bonus or long-term incentive opportunities may be offered.

Company Description

Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients over the last three decades, SCRI is a leader in drug development.

• In 2022, SCRI formed a joint venture with former US Oncology Research to expand clinical trial access across the country.
• Conducted more than 850 first-in-human clinical trials since its inception.
• Contributed to pivotal research that has led to the majority of new cancer therapies approved by the FDA in the past decade.
• Research network brings together more than 1,300 physicians enrolling patients into clinical trials at more than 200 locations in 20+ states across the U.S.